selected publications
-
academic article
- Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G2/M arrest in glioblastoma cell lines. ONCOGENE. 7185-7193. 2007
- Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines. . MOLECULAR CANCER RESEARCH. 641-653. 2007
- Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells. . INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. 1877-1885. 2007
- Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells. MOLECULAR CANCER THERAPEUTICS. 2172-2181. 2006
- Inhibition of Hsp90 function causes dowregulation of cdc2 and cdc25C and G2/M arrest in glioblastoma cell lines. . ONCOGENE. 2006
- Differential regulation of cyclin D3 by rapamycin in HER2 overexpressing breast cancer cells. MOLECULAR CANCER THERAPEUTICS. 2005
- Differentiation and drug resístanse relationships in leukemia cells. JOURNAL OF CELLULAR BIOCHEMISTRY. 98-108. 2005
- Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines.. MOLECULAR CANCER THERAPEUTICS. 1222-1230. 2005
-
congress communication
- Epidermal growth factor receptor inhibition reduces cell proliferation of glioblastoma multiforme cell lines. . 45-45. 2007
- La inhibición de rutas de transducción de señales como estrategia terapéutica en glioblastoma multiforme 2007
- PARP-1 inhibitors potentiate the histone deacetylase inhibitors-induced apoptosis in tumour cell lines from different origin. 44-44. 2007
- Study of the interaction between trichostatin and rapamycin in pancreatic-adenocarcinoma cell lines. 43-43. 2007
- Geldanamycin causes a G2/M arrest in glioblastoma cell lines 2006
- Insights on histone deacetylase inhibitors-induced apoptosis in hematopoietic cell lines 2006
- Insights on histone deacetylase inhibitors-induced apoptosis in pancreatic adenocarcinoma cell lines 2006
- Los inhibidores de PARP-1 potencian la apoptosis inducida por los inhibidores de las desacetilasas de histonas en diversas líneas celulares tumorales 2006
- Los inhibidores de las desacetilasas de histonas en el tratamiento del cáncer 2006
- Desarrollo y evaluación de nuevos abordajes terapéuticos y de modelos de experimentación animal para el tratamiento del carcinoma de páncreas exocrino 2005
- La apoptosis inducida por los inhibidores de las desacetilasas de histonas es dependiente de la actividad de una o varias serín-proteasas en varios modelos celulares quimiorresistentes 2005
- Los inhibidores de PARP-1 potencian la apoptosis inducida por los inhibidores de desacetilasas de histonas en diversas líneas celulares tumorales 2005
- Los inhibidores de las desacetilasas de histonas (iHDACs) inducen apoptosis caspasa-independiente y serín proteasa-dependiente en líneas celulares de adenocarcinoma humano de páncreas exocrino 2005
- Regulación de la ciclina D3 por la rapamicina en células que sobreexpresan HER2 2005
-
thesis